The success story of BIOCAD biotechnology company
The BIOCAD biotechnology company was founded 16 years ago. During this time, it has taken a leading position in the Russian pharmaceutical market and has become one of the few companies in the world engaged in the full cycle of drug development: from the search for molecules to mass production. BIOCAD preparations are designed to treat the most complex diseases, such as cancer, HIV, hepatitis, multiple sclerosis. The mission of the company is to increase the life expectancy of Russians, providing them with affordable vital medicines. The global goal is to become the world’s most innovative biotechnology company.
Dmitry Morozov, General director, BIOCAD